Ophthalmology · Southfield, MI
NPI
1942258306
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
29201 Telegraph Rd, Suite 301
Southfield, MI, 48034
Phone (248) 356-0098
Groups this clinician bills Medicare through
Medicare paid, 2024
$344K
6,062 services
Medicare patients, 2024
872
Average age 75
Drug cost, 2024
$667K
11,140 prescriptions
Company payments, 2025
$515
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew E Citron was code 92083 (vision, hearing, and speech services), 1,002 times for 742 patients. In total Matthew E Citron billed 6,062 services in 40 codes, and Medicare paid $344K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92083 Vision, Hearing, and Speech Services | Office | 1,002 | 742 | $43.26 | $43K |
| 99214 Office E&M - Established | Office | 928 | 636 | $83.75 | $78K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 904 | 499 | $12.96 | $12K |
| 92020 Ophthalmological E&M | Office | 679 | 637 | $19.52 | $13K |
| 92250 Angiography | Office | 679 | 671 | $21.06 | $14K |
| 92133 Computerized Ophthalmic Imaging | Office | 500 | 487 | $22.84 | $11K |
| 99213 Office E&M - Established | Office | 429 | 262 | $66.60 | $29K |
| 92014 Ophthalmological E&M | Office | 185 | 155 | $70.28 | $13K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 98 | 64 | $188.14 | $18K |
| 76514 Ultrasound - Nonspecific | Office | 91 | 90 | $8.23 | $749 |
| 99204 Office E&M - New | Office | 91 | 91 | $110.48 | $10K |
| 92136 Ultrasound - Nonspecific | Office | 82 | 44 | $28.88 | $2,368 |
| 92025 Test - Miscellaneous | Office | 53 | 51 | $25.31 | $1,341 |
| 66988 Cataract Surgery | Facility | 36 | 22 | $356.35 | $13K |
| 66984 Cataract Surgery | Facility | 32 | 20 | $410.24 | $13K |
By year: 2022 $319K for 4,527 services; 2023 $351K for 5,164 services; 2024 $344K for 6,062 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew E Citron prescribed most often to Medicare patients was Latanoprost, with 3,749 prescriptions and refills. In total Matthew E Citron wrote 11,140 Medicare prescriptions that cost $667K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 3,749 | 8,018 | 1,019 | $70K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,645 | 3,599 | 454 | $41K |
| Brimonidine Tartrate Generic | 1,345 | 2,757 | 378 | $26K |
| Timolol Maleate Generic | 1,093 | 2,426 | 346 | $24K |
| Prednisolone Acetate Generic | 849 | 1,250 | 481 | $43K |
| Ofloxacin Generic | 251 | 300 | 208 | $2,895 |
| Dorzolamide Hcl Generic | 235 | 491 | 69 | $7,251 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 203 | 355 | 61 | $39K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 171 | 179 | 132 | $2,194 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 161 | 240 | 35 | $79K |
| Rhopressa Netarsudil Mesylate | 149 | 217 | 37 | $61K |
| Lumigan Bimatoprost | 130 | 196 | 29 | $46K |
| Atropine Sulfate Generic | 117 | 153 | 85 | $4,376 |
| Brinzolamide Generic | 105 | 202 | 37 | $20K |
| Combigan Brimonidine Tartrate/Timolol | 103 | 200 | 38 | $42K |
Brand drugs: 2,674 claims; generic drugs: 8,466 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew E Citron $515 ($515 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sight Sciences, Inc. with $415.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.